AI assistant
Sending…
ABB Ltd — Major Shareholding Notification 2020
Aug 5, 2020
803_iss_2020-08-05_2667ece3-c1e6-45d5-af05-f44f3dc2085f.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer ABB Ltd
Holder
Cevian Capital II GP Limited
Instrument
Instrument Ordinary shares CH0012221716
| Before the transaction | |
|---|---|
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 30/07/2020 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 107,344,554 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 107,344,554 |
| Percentage | |
| Directly held shares | 4.95098 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.95098 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.95098 % | 107,344,554 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 4.95098 % | 107,344,554 |
Chain of controlling companies
| Voting rights % Voting rights Company | ||
|---|---|---|
| 95,675,598 4.41278 | Cevian Capital II Master Fund LP | |
| 11,668,956 0.5382 | Cevian Capital II Co-Investment Fund LP | |
| Group total holdings |
||
| Voting rights | 107,344,554 | |
| Percentage of voting rights 4.95098 |
Published
05/08/2020 10:08
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from ABB Ltd
Transaction in Own Shares
2026
May 21
Transaction in Own Shares
2026
May 21
Transaction in Own Shares
2026
May 21
Transaction in Own Shares
2026
May 14
Transaction in Own Shares
2026
May 14
Transaction in Own Shares
2026
May 14
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 30